Need help? Our team of experienced experts is here for you with full support.
CP-089
AktiPep™ PT8 Palmitoyl Tripeptide-8
Cat. No.
CP-089
CAS No.
936544-53-5
MF
C37H61N9O4
MW
695.94
AktiPep™ PT8 Palmitoyl Tripeptide-8 is a synthetic lipopeptide with the sequence L-His–D-Phe–L-Arg, an N-terminal palmitoyl group, and an amidated C-terminus.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
AktiPep™ PT8 Palmitoyl Tripeptide-8
CAS No.
936544-53-5
MF
C37H61N9O4
MW
695.94
Specification
98%
Research area
Sensitive-skin care, soothing, redness reduction
Description
AktiPep™ PT8 Palmitoyl Tripeptide-8 is a synthetic lipopeptide with the sequence L-His–D-Phe–L-Arg, an N-terminal palmitoyl group, and an amidated C-terminus. Packing:1kg/bag,25kg/drum or as request Availability: In stock
Documents
Storage and Shipping
Short-term storage: at 2–8°C in a tightly closed container, in a dry place, protected from light.
Long-term storage: at −20°C in a tightly closed container, in a dry place, protected from light.
References
[1].Martinez J, Verdie P, Dubs P, Pinel AM, Subra G, inventors. MSH-agonist tripeptide conjugates. United States patent US8017581B1. 2011 Sep 13.
[2].Resende DISP, Ferreira MS, Sousa-Lobo JM, Sousa E, Almeida IF. Usage of synthetic peptides in cosmetics for sensitive skin. Pharmaceuticals (Basel). 2021;14(8):702. doi:10.3390/ph14080702
[3].Baldwin H, Berson D, Vitale M, Yatskayer M, Chen N, Oresajo C. Clinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topical or oral therapy for papulopustular rosacea. J Drugs Dermatol. 2014;13(3):326–331. PMID:24595579
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.